Concepedia

Author

Michaël Angioı̈

Centre Hospitalier Régional et Universitaire de Nancy

Also Known As

ANGIOI, Michael, M Angioi, M Angioï, M. Angioi, M. Angioï, Michael Angioi, Michael Angioï, Michaël Angioï, Michaël Angioi, Michaël Angioï

94

Publications

2.3K

Citations

20

H-Index

45

Concepts

All Affiliations

Centre Hospitalier Régional et Universitaire de NancyInsermClinique PasteurHôpital Bichat-Claude-BernardPfizer (United States)
MA

About

Michaël Angioı̈ is an author at Centre Hospitalier Régional et Universitaire de Nancy specializing in cardiovascular disease, medicine, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

17

1.4K

2

Public Health

4

4

218

3

Engineering

2

2

43

4

Health Sciences

2

2

57

5

Applied Physiology

1

1

27

Michaël Angioı̈

×

28

Publications

2.2K

Citations

19

H-Index

YearCitations

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni,

The Lancet

2018

761

Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure

Wafae Iraqi, Patrick Rossignol, Michaël Angioı̈,

Circulation

2009

256

C-Reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes

Idrissia Abdelmouttaleb, Nicolas Danchin, Claudio Ilardo,

American Heart Journal

1999

129

Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the Drug

Benoît Labarthe, Pierre Théroux, Michaël Angioı̈,

Journal of the American College of Cardiology

2005

126

Treatment of Acute Myocardial Infarction by Primary Coronary Angioplasty or Intravenous Thrombolysis in the “Real World”

Nicolas Danchin, L Vaur, N Genès,

Circulation

1999

118

Timing of Eplerenone Initiation and Outcomes in Patients with Heart Failure After Acute Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction: Insights from the EPHESUS Trial

Chris Adamopoulos, Ali Ahmed, Renaud Fay,

European Journal of Heart Failure

2009

94

Effect of late percutaneous angioplastic recanalization of total coronary artery occlusion on left ventricular remodeling, ejection fraction, and regional wall motion

Nicolas Danchin, Michaël Angioı̈, Romain Cador,

The American Journal of Cardiology

1996

79

Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry

Mohamed O. Mohamed, Jawed Polad, David Hildick‐Smith,

EuroIntervention

2020

70

Detection of myocarditis by contrast‐enhanced MRI in patients presenting with acute coronary syndrome but no coronary stenosis

Andreï Codreanu, Michaël Angioı̈, Gérard Éthevenot,

Journal of Magnetic Resonance Imaging

2007

65

A Direct Comparison of Intravenous Enoxaparin With Unfractionated Heparin in Primary Percutaneous Coronary Intervention (from the ATOLL Trial)

Jean‐Philippe Collet, Kurt Huber, Marc Cohen,

The American Journal of Cardiology

2013

56

Page 1